|
Volumn 13, Issue 24, 2005, Pages 6685-6692
|
Tetra substituted thiophenes as anti-inflammatory agents: Exploitation of analogue-based drug design
|
Author keywords
Anti inflammatory activity; Drug designs; Tetra substituted thiophenes
|
Indexed keywords
2 CARBETHOXYAMINO 5 (2 CARBOXANILIDOACETYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 CARBETHOXYAMINO 5 (2 ETHOXYCARBONYL 2 HYDROXYIMINOACETYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 CARBETHOXYAMINO 5 (2 ETHOXYCARBONYL 2 METHOXYIMINOACETYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 CARBETHOXYAMINO 5 (3,5 DIMETHYL 4 METHOXY 2 PYRIDYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 CARBETHOXYAMINO 5 (4 METHYLMERCAPTOBENZOYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 CARBETHOXYAMINO 5 (4 METHYLSULFONYLBENZOYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 ETHYLAMINO 5 (2 ETHOXYCARBONYL 2 ACETYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 ETHYLAMINO 5 (2 ETHOXYCARBONYL 2 HYDROXYIMINOACETYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 ETHYLAMINO 5 (2 ETHOXYCARBONYL 2 METHOXYIMINOACETYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 ETHYLAMINO 5 (3,5 DIMETHYL 4 METHOXY 2 PYRIDYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 ETHYLAMINO 5 (4 METHYLMERCAPTOBENZOYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 ETHYLAMINO 5 (4 METHYLSULFONYLBENZOYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 METHYLAMINO 5 (2 ETHOXYCARBONYL 2 HYDROXYIMINOACETYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 METHYLAMINO 5 (2 ETHOXYCARBONYL 2 METHOXYIMINOACETYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 METHYLAMINO 5 (3,5 DIMETHYL 4 METHOXY 2 PYRIDYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 METHYLAMINO 5 (4 METHYLMERCAPTOBENZOYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
2 METHYLAMINO 5 (4 METHYLSULFONYLBENZOYL) 4 METHYLTHIOPHENE 3 CARBOXYLIC ACID METHYL ESTER;
ACRYLIC ACID;
ANTIINFLAMMATORY AGENT;
AP 11;
AP 121;
AP 155;
AP 156;
AP 157;
AP 45;
AP 46;
AP 53;
AP 56;
AP 57;
AP 58;
AP 59;
AP 60;
AP 61;
AP 62;
AP 63;
CARRAGEENAN;
ESTER;
LIPOXYGENASE INHIBITOR;
PEROXY RADICAL;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ROMAZARIT;
TENIDAP;
THIOPHENE;
THIOPHENE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BIOLOGICAL ACTIVITY;
CHEMICAL BOND;
DRUG DESIGN;
DRUG SCREENING;
DRUG SYNTHESIS;
FEMALE;
IN VIVO STUDY;
INFLAMMATION;
MALE;
METABOLISM;
NONHUMAN;
PAW EDEMA;
PHARMACOPHORE;
RAT;
TOXICITY;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
CARRAGEENAN;
DRUG DESIGN;
EDEMA;
EXTREMITIES;
FEMALE;
MALE;
MOLECULAR STRUCTURE;
RATS;
RATS, SPRAGUE-DAWLEY;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIOPHENES;
ANIMALIA;
|
EID: 27644594573
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2005.07.044 Document Type: Article |
Times cited : (74)
|
References (21)
|